The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conditional disposal of interest-Investee Company

2 Aug 2016 12:08

RNS Number : 0087G
Braveheart Investment Group plc
02 August 2016
 

 

2 August 2016

Braveheart Investment Group plc

('Braveheart', the 'Company' or the 'Group')

 

Conditional disposal of interest in Investee Company

 

Further to the announcement on 29 July 2016, the board of Braveheart is pleased to announce that it has agreed terms to conditionally sell its 1.25 per cent. interest and the 3.75 per cent. interest held by Strathclyde Investment Fund ("SIF"), in which the Group has an 89.3 per cent. interest, in mLED Limited ("mLED") to a large US based technology company. The sale is conditional, inter alia, on the termination of certain employee and other contracts and on subsequent completion of the transaction (expected in early September, but by no later than early November). The cost of terminating these contracts will be offset against the sale proceeds.

The total net consideration to be paid to the Group is to be satisfied entirely in cash. It is estimated that the Group will receive a total net consideration of £381,000.

mLED provides ultra-high brightness microLED array technology for the fast growing markets of Near-To-Eye, Head-Up-Display, Wearables, Printing and Lithography. The company is a spin-out from the University of Strathclyde. At 31 March 2016, the net book value of the interest held by the Group was £96,000. Accordingly, the estimated total net consideration receivable will result in a profit to the Group of £285,000.

The proceeds of the sale of the mLED shares, as and when received, will increase the Group's cash reserves and will be used for investing in suitable opportunities in accordance with the Group's investment strategy and for working capital generally.

Given the outstanding conditions of the sale, there can be no certainty that the transaction will be completed. A further announcement will be made in due course.

Further information:

Braveheart Investment Group plc

Trevor Brown, CEO Tel: +44 1738 587555

 

Allenby Capital Limited (Nominated Adviser and Broker to Braveheart)

David Worlidge / James Thomas Tel: +44 20 3328 5656

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFPAEEXKEFF
Date   Source Headline
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSAcquisition of further interest in Aukett Swanke
31st Aug 20225:00 pmRNSTotal Voting Rights
4th Aug 20223:27 pmRNSHolding(s) in Company
3rd Aug 20225:05 pmRNSAcq of interest in Aukett Swanke plc - Replacement
3rd Aug 20224:10 pmRNSAcquisition of interest in Aukett Swanke Group plc
21st Jul 20227:03 amRNSOperational update on Paraytec
13th Jul 202211:41 amRNSResult of AGM
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
27th Jun 20228:40 amRNSDirector/PDMR Shareholding
16th Jun 20227:00 amRNSFinal Results
9th May 20223:57 pmRNSReplacement - Cancellation and grant of options
9th May 20221:08 pmRNSCancellation and grant of options
29th Apr 20225:00 pmRNSTotal Voting Rights
6th Apr 20227:00 amRNSPlacing to raise £215,113
31st Mar 202212:17 pmRNSResult of General Meeting
28th Mar 20229:42 amRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSNotice of GM and authority to issue shares
14th Mar 202211:23 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSBlock admission six monthly return
8th Mar 20229:41 amRNSDirector/PDMR Shareholding
25th Feb 202211:06 amRNSSecond Price Monitoring Extn
25th Feb 202211:00 amRNSPrice Monitoring Extension
25th Feb 20227:00 amRNSOperational update
31st Jan 20227:00 amRNSHolding(s) in Company
28th Jan 20221:55 pmRNSHolding(s) in Company
21st Jan 20222:46 pmRNSOperational update on Paraytec
17th Jan 20223:23 pmRNSFurther re. Director/PDMR holding
17th Jan 20229:24 amRNSHolding(s) in Company
16th Dec 20217:00 amRNSNon Regulatory - PhaseFocus Update
8th Dec 20214:08 pmRNSDirector/PDMR Shareholding
8th Dec 20217:00 amRNSOperational update on Paraytec
26th Nov 20219:49 amRNSVideo from The University of Sheffield re Paraytec
15th Nov 20217:00 amRNSHalf-year Report
14th Oct 20211:46 pmRNSDirector/PDMR Shareholding
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Sep 20215:00 pmRNSTotal Voting Rights
30th Sep 20217:00 amRNSOperational update on various investments
28th Sep 202112:14 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSBlock admission six monthly return
31st Aug 20215:00 pmRNSTotal Voting Rights
13th Aug 202111:05 amRNSSecond Price Monitoring Extn
13th Aug 202111:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSPlacing to raise £2.5 million
6th Aug 202111:05 amRNSSecond Price Monitoring Extn
6th Aug 202111:00 amRNSPrice Monitoring Extension
4th Aug 20212:40 pmRNSFurther update re Paraytec AD Scanner project
26th Jul 20215:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.